← All issues

Weekly AI digest

Radiology & medical imaging AI · week of 4 to 10 October 2026

199 peer-reviewed papers · 5 industry and regulatory items · conference and KOL highlights. Adapted from my weekly intelligence report. Full report: FR (PDF) · EN (PDF) · RU (PDF).

Governance takeaway

What to do about it this week

Name the owner. Article 4 of the EU AI Act makes AI literacy an organizational obligation, and this week supplies both the map and the motive: EFOMP's new framework turns AI competence into an auditable professional ladder with six named gaps, and a carotid ultrasound reader study shows why it matters, with AI assistance lifting junior readers from near-chance baselines to usable but still below unassisted seniors.

This week, assign one named, competent owner to each deployed model and have them produce a single signed page: what the tool is cleared for, what your acceptance test showed, which patient subgroups and reader groups were checked, and what triggers suspension.

Regulation & AI Act watch

Evidence you can use

Selected from 199 papers indexed in PubMed this week.

Post-market signal

Two compliance analyses published this week work through what the Digital Omnibus (Regulation (EU) 2026/1744, consolidated text since 27 July 2026) did to post-market monitoring under the EU AI Act. The implementing act that was to fix a mandatory monitoring-plan template by 2 February 2026 was never adopted and has been replaced: the Commission now owes guidance, including a template the amending act's recitals call voluntary, by 2 September 2027. Article 72's substantive duty is unchanged and formally applies from 2 August 2026, while the high-risk classification rules it attaches to now apply from 2 December 2027 (Annex III) and 2 August 2028 (Annex I, which covers MDR devices); how those dates fit together is openly flagged as unresolved.

The practical consequence for imaging: anyone waiting for an official template before starting monitoring is waiting for a voluntary document arriving late next year. Write the plan against Article 72(1) and (2) now, with named metrics, baselines, data sources, thresholds and a review cadence, and integrate it with the MDR post-market surveillance file your vendors already owe you. A device-focused reading of the amended text adds two concrete points: MDCG 2025-6 makes monitoring of interactions between AI systems the main genuinely new expectation, and Article 12 logging is a design requirement that must exist in the product, not only in a procedure.

The same signal came from the field this week: EuSoMII's annual meeting ran a dedicated post-market surveillance how-to session, and European informatics voices are explicitly calling for an EU equivalent of the ACR's Assess-AI registry.

Playbook snippet

One step for your AI committee

Anchor: EU AI Act Article 4 (AI literacy), applying since February 2025. The AI Act application calendar is under revision following the Digital Omnibus, so verify enforcement dates against the current text.

Step: Pick one deployed model. Produce a single signed and dated page: what it is cleared for, what your acceptance test showed, which patient subgroups and reader groups were checked, and what triggers suspension.

Why: A certificate proves attendance; a completed audit page proves the person can tell when the model is failing in their own population, which is what an inspector, and your own quality committee, will actually ask.

Worked example: Sun Y et al. (Academic Radiology, PMID 42855384, DOI 10.1016/j.acra.2026.09.036) show what the reader-group line of that page should contain: external-cohort AUC 0.939, senior readers improved from 0.868 to 0.929 with assistance, juniors from 0.548 to 0.659. If your acceptance test cannot show this split for your own readers, the audit page is not complete.

From the field

EuSoMII held its annual meeting in Heraklion on 9 and 10 October with a program that read like a governance syllabus: a dedicated post-market surveillance how-to session, the ACR Data Science Institute presenting its governance and monitoring programs including the Assess-AI registry, joint sessions with ESNR, SIIM, EFRS and MICCAI, and a keynote on European Health Data Space readiness.

JFR 2026 ran in Paris from 8 to 10 October with AI across the program. The emergency-imaging session carried the week's refrain: published performance never guarantees local performance, and drift monitoring belongs to deployment. One number stood out, from a Lancet-published randomized evaluation quoted there: 40% of practitioners had stopped using an AI tool within twelve months, and usage rate, not accuracy, determined its impact.

RSNA introduced an AI certificate program for imaging professionals on 4 October. Structured certification maps onto the Article 4 literacy obligation, but the distinction stands: a certificate documents training, while a completed model audit documents competence.

On LinkedIn, Daniel Pinto dos Santos amplified the ACR's Assess-AI message from EuSoMII, calling post-market surveillance urgently needed in the EU as well; Amine Korchi announced an investment in Vocca, AI voice agents for clinic phone lines, as a signal of where radiology-adjacent money is moving; and Matt Lungren explained his January departure from Microsoft with the launch of Oku Digital Health from Topcon, a bet that the next clinical AI platform grows out of eye care.

Source articles are indexed in PubMed with verified DOIs. Manuscript-stage work is excluded. The full weekly report is produced in French.

Get the weekly digest

One email a week on what matters in radiology and imaging AI. Researched by a radiologist and imaging informatics professional. Free, no vendor sponsorship.